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Dear Editor,
In their retrospective study, Leonardi and La Rosa (2010) did 
not find any instances of celiac disease (CD) among hepatitis B 
virus carrier patients (1). CD is an inflammatory, immune-me-
diated intestinal disorder triggered by ingested wheat gluten 
in genetically susceptible individuals (2). Leonardi and La Rosa 
(2010) found CD antibodies (immunoglobulin A and G antiglia-
din) in 11.6% of the cases, but no patient had immunoglobulin 
A antiendomysium or immunoglobulin A antitissue transgluta-
minase; consequently, a diagnosis of CD was ruled out. Even if 
a relationship between CD and hepatitis B virus had been pres-
ent, the study could have been unable to detect a significant 
association due to the small sample size. Several studies have 
demonstrated a close association between CD and autoimmune 
disorders, such as insulin-dependent diabetes mellitus, thyroid 
disorders, dermatitis herpetiformis, Addison’s disease, autoim-
mune myocarditis, Sjögren’s syndrome, autoimmune hepatitis, 
autoimmune cholangitis, vasculitis, polydermatomyositis, sys-
temic lupus erythematosus, and rheumatoid arthritis (3, 4). In 
the field of the neurological diseases, we reported a possible link 
between CD and optic neuromyelitis (5), an inflammatory disor-
der of the central nervous system of autoimmune etiology (6). 
It is still debatable whether organ-specific autoantibodies sus-
taining CD represent an epiphenomenon or the expression of 
associated autoimmune disorders, but it seems very likely that 
an autoimmune environment might also trigger an abnormal 
response to gliadin. In the same way, hepatitis B and hepatitis C, 
which may have aminoacid sequences homologous to the toxic 
epitopes in gliadin, could trigger immunologic gluten intoler-
ance in susceptible patients (7). Thus, the hypothesis that non-
intestinal diseases (such as hepatitis B and C or other inflamma-
tory pathologies) may trigger immunologic gluten intolerance 
in susceptible subjects is still open to evaluation. Another con-
troversial point investigated by Leonardi and Rosa (1) was the 
possible activation of CD due to the treatment of viral hepatitis 
with interferon-α (IFN-α; (8)) because of its immune modulating 
properties (e.g., producing dendritic cells that contribute to the 
Th1 response; (9)). Similar to CD, multiple sclerosis (MS), which 
is the most important neurological inflammatory autoimmune 
disease, is considered a “Th1 disease”. Treatments of MS largely 
use a kind of IFN different from that used to treat hepatitis. Par-
ticularly, IFN-ß is able to reduce the risk of MS relapses through 
the down-regulation of proinflammatory Th1 responses (10). 
In fact, no case of CD has been described among the numerous 
MS patients treated with IFN-ß in the literature so far. In regard 
to the different (and somehow opposite) mechanisms of IFN-ß 
compared to those of IFN-ß, the absence of CD activation in pa-
tients treated with IFN-ß could indirectly support the possibility 
of CD onset as a consequence of IFN-α therapy.
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